TP53 and neoplasm: TP53 is a tumour suppressor and occurs at rates ranging from 38% to 50% in oesophageal, ovarian, colorectal, lung and larynx cancers to ~5% in primary leukaemia, sarcoma, testicular cancer, malignant melanoma and cervical cancer.